Switch to:

Denali Therapeutics Debt-to-Asset

: 0.12 As of Sep. 2019
View and export this data going back to 2017. Start your Free Trial

Denali Therapeutics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $0.0 Mil. Denali Therapeutics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2019 was $69.9 Mil. Denali Therapeutics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2019 was $603.0 Mil. Denali Therapeutics's debt to asset for the quarter that ended in Sep. 2019 was 0.12.


Denali Therapeutics Debt-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
Debt-to-Asset 0.00 0.00 0.00 0.00

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.11 0.11 0.12

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics Debt-to-Asset Distribution

* The bar in red indicates where Denali Therapeutics's Debt-to-Asset falls into.



Denali Therapeutics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Denali Therapeutics's Debt-to-Asset Ratio for the fiscal year that ended in Dec. 2018 is calculated as

Denali Therapeutics's Debt-to-Asset Ratio for the quarter that ended in Sep. 2019 is calculated as

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics  (NAS:DNLI) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Denali Therapeutics Debt-to-Asset Related Terms


Denali Therapeutics Debt-to-Asset Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */